SCHEMBL25596187

SCHEMBL25596187

CCc1cc(CC(C)(N)CF)ccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.53
KDM4E B2RXH2 3/20 0.45
MAPT P10636 3/20 0.45
ALOX15 P16050 3/20 0.45
HSD17B10 Q99714 3/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 2/20 0.45
POLB P06746 2/20 0.45
CYP3A4 P08684 2/20 0.45
HPGD P15428 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
BLM P54132 2/20 0.45
MEN1 O00255 1/20 0.45
USP2 O75604 1/20 0.45
EGFR P00533 1/20 0.45
FYN P06241 1/20 0.45
GAA P10253 1/20 0.45
APEX1 P27695 1/20 0.45
ADRA1A P35348 1/20 0.45
PTGS2 P35354 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25596291 0.82 KDM4E (0.45) BACE1KDM4EMAPTALOX15HSD17B10
SCHEMBL25596190 0.81 ESR1 (0.52) KDM4EMAPTALOX15HSD17B10ALDH1A1
SCHEMBL22074747 0.81 KDM4E (0.49) BACE1KDM4EMAPTALOX15HSD17B10
SCHEMBL25596189 0.79 CA2 (0.47) KDM4EMAPTALOX15HSD17B10ALDH1A1
SCHEMBL6340510 0.78 KDM4E (0.74) BACE1KDM4EMAPTALOX15HSD17B10
SCHEMBL6340509 0.78 KDM4E (0.74) BACE1KDM4EMAPTALOX15HSD17B10
SCHEMBL1021944 0.73 BACE1 (0.68) BACE1KDM4EMAPTALOX15HSD17B10
SCHEMBL4232469 0.73 BACE1 (0.50) BACE1KDM4EMAPTALOX15HSD17B10
SCHEMBL13513525 0.72 BACE1 (0.72) BACE1KDM4EMAPTALOX15HSD17B10
SCHEMBL1022604 0.72 BACE1 (0.72) BACE1HSD17B10CYP3A4ADRA1AESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230181493-A1 BIOMARKERS RELATED TO PARKINSON'S DISEASE AND METHODS OF USING THE SAME SENDA BIOSCIENCES INC (US) 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230181493-A1 BIOMARKERS RELATED TO PARKINSON'S DISEASE AND METHODS OF USING THE SAME COMT, SNCA, PARK7 BACE1 565/4885KDM4E 945/4885MAPT 732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.